Summary
The pharmacokinetics of albendazole were investigated in healthy volunteers and in patients receiving albendazole for treatment of hydatid disease. Unchanged albendazole was below detectable limits in plasma, urine, bile and cyst fluid. The major metabolite present in all fluids was the sulfoxide. Maximum concentrations of albendazole sulfoxide in plasma were very variable, probably due to variable absorption of albendazole.
Similar content being viewed by others
References
Marriner SE, Bogan JA (1980) Pharmacokinetics of albendazole in sheep. Am J Vet Res 41: 1126–1129
Gyurik RJ, Chow AW, Zaber B, Brunner EL, Miller JA, Villani AJ, Petka LA, Parish RC (1981) Metabolism of albendazole in cattle, sheep, rats and mice. Drug Metab Dispos 9: 503–508
Morris DL, Dykes PW, Dickson B, Marriner SE, Bogan JA, Burrows FGO (1983) Albendazole in hydatid disease. Br Med J 286: 103–104
Munst GJ, Karlanganis G, Bircher J (1980) Plasma concentrations of mebendazole during treatment of Echinococcosis. Eur J Clin Pharmacol 17: 375–378
Bogan JA, Marriner SE (1980) Analysis of benzimidazoles in body fluids by high performance liquid chromatography J Pharm Sci 69: 422–423
Bryceson ADM, Woestenborghs R, Michiels M, Van Den Bossche H (1982) Bioavailability and tolerability of mebendazole in patients with inoperable hydatid disease. Trans R Soc Trop Med Hyg 76: 563–564
Morris DL, Gould SE (1982) Serum and cyst concentrations of mebendazole and flubendazole in hydatid disease. Br Med J 285: 175–179
Witassek F, Burkhardt B, Eckert J, Bircher J (1981) Chemotherapy of alveolar echinococcosis. Eur J Clin Pharmacol 20: 427–433
Braithwaite PA, Roberts MS, Allan RJ, Watson TR (1982) Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease. Eur J Clin Pharmacol 22: 161–169
Meuldermans WEG, Hurkmans RMA, Lauwers WFJ, Heykants JJP (1976) The in vitro metabolism of mebendazole by pig, rat and dog liver fractions. Eur J Drug Metab Pharmacokinet 1: 35–40
Luder PJ, Witassek F, Weigand K, Eckert J, Bircher J (1985) Treatment of cystic echinococcosis(Echinococcus granulosus) with mebendazole. Assessment of bound and free drug levels in cyst fluid and of parasite vitality in operative specimens. Eur J Clin Pharmacol 28: 279–285
Waring RM, Mitchell SC, Shah RR, Idle JR, Smith RL (1982) Polymorphic sulphoxidation of S-carboxylmethyl-l-cysteine in man. Biochem Pharmacol 31: 3151–3154
Dawson M, Watson TR (1985) The effect of dose form on the bioavailability of mebendazole in man. Br J Clin Pharmacol 19: 87–90
Theodorides VJ, Nawalinski T, Chang J (1976) Efficacy of albendazole against gastrointestinal nematodes of cattle. Am J Vet Res 37: 1517–1518
Theodorides VJ, Nawalinski T, Chang J (1976) Efficacy of albendazole againstHaemonchus Nematodirus Dictyocaulus andMonezia of sheep. Am J Vet Res 37: 1515–1516
Rossignol JF, Couland JP (1982) Proceedings of Symposium; Albendazole in Helminthiasis, Nairobi, June 1982. R Soc Med 57: 19–25
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marriner, S.E., Morris, D.L., Dickson, B. et al. Pharmacokinetics of albendazole in man. Eur J Clin Pharmacol 30, 705–708 (1986). https://doi.org/10.1007/BF00608219
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00608219